The Treatment Timebomb
Brazilian Patent Office Issues Final Refusal for Tenofovir – But Gilead Files Divisional Application
UK All-Party Parliamentary Group on Aids to Urge Companies to Pool HIV Patents
Update India: Abbott Files a Divisional Application for its Heat Stable Ritonavir/Lopinavir Formulation
World Aids Day – Access to Life
Brazilian Patent Office Confirms Refusal of Tenofovir Patent Application
USPTO Confirms Gilead’s Remanining Patents for Tenofovir as Valid
US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil
Brazilian Patient Group Joins With Indian Group to Challenge Tenofovir Patent in India
Delhi Patent Office Refuses Patent on Pediatric Aids Drug Nevirapine Hemiydrate